Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM0YW5Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological or dental drugs
XM01G3Silver

XM9R64 category

Silver sulfadiazine

Also indexed as

Silver sulfadiazine

Nearby in Silver

XM0CN1Silver anti-infectives
XM3QX7Silver colloidal
XM2U36Silver nitrate ophthalmic preparation
XM6RF0Silver nitrate

PreviousXM2U36 — Silver nitrate ophthalmic preparation NextXM6RF0 — Silver nitrate

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
XM4G94Antidepressants
XM98Y0Cannabinoids or hallucinogens
XM9NV2Opioids
XM0RE9Psychostimulants
XM3L75Sedative hypnotic drugs or other central nervous system depressants
XM16M6Other or unspecified drugs, medicaments and biological substances
XM0YW5Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological or dental drugs
14 more
Otorhinolaryngological drugs and preparations
XM5HX7Podophyllin
Topical corticosteroid preparations
XM5PA8Ufenamate
XM3VA9Chlorphenesin
XM2NU3Idrocilamide
XM6H69Methyl salicylate
Retinoids topical
XM01G3Silver
12 more
XM0CN1Silver anti-infectives
XM3QX7Silver colloidal
XM2U36Silver nitrate ophthalmic preparation
XM9R64Silver sulfadiazine
XM6RF0Silver nitrate

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact